Sarcopenia as a Prognostic Factor in Oncological and Chronic Conditions
Abstract
Dear Editor, I read the recent article with great interest (title: The Relationship of Sarcopenia With Prognosis in Patients Diagnosed with Metastatıc Gastric Cancer Receiving Palliative Chemotherapy) exploring the relationship between sarcopenia and prognosis in metastatic gastric cancer patients on palliative chemotherapy, which was published in your journal [1]. The findings align with a growing body of literature demonstrating that sarcopenia is a clinically significant prognostic factor, yet several points merit emphasis, clarification, or further exploration to strengthen both the interpretation and implications for clinical practice.
Keywords
References
- 1. Gökçin Z, Özçelik M, Kulalı F, Emir SN, Uçak Basat S. The relationship of sarcopenia with prognosis in patients diagnosed with metastatic gastric cancer receiving palliative chemotherapy. DAHUDER Medical Journal. 2025;5(3):101- 8. doi:10.56016/dahudermj.1709426.
- 2. Lee JS, Kim YS, Kim EY, Jin W. Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer. PLoS One. 2018;13(8):e0202700. doi:10.1371/ journal.pone.0202700.
- 3. Sugiyama K, Narita Y, Mitani S, Honda K, Masuishi T, Taniguchi H, et al. Baseline sarcopenia and skeletal muscle loss during chemotherapy affect survival outcomes in metastatic gastric cancer. Anticancer Res. 2018;38(10):5859- 66. doi:10.21873/anticanres.12928.
- 4. Zurlo V, Rosa F, Rinninella E, Pontolillo L, Beccia V, Maratta M, et al. Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment. Eur Rev Med Pharmacol Sci. 2024;28(4):1575- 84. doi:10.26355/eurrev_202402_35486.
- 5. Dogan O, Sahinli H, Duzkopru Y, Akdag T, Kocanoglu A. Is sarcopenia effective on survival in patients with metastatic gastric cancer? World J Gastrointest Oncol. 2024;16(5):1861- 8. doi:10.4251/wjgo.v16.i5.1861.
- 6. Kocak MZ, Aktas G, Atak B, Bilgin S, Kurtkulagi O, Duman TT, et al. The association between vitamin D levels and handgrip strength in elderly men. Acta Endocrinol (Buchar). 2020;16(2):263-6. doi:10.4183/aeb.2020.263.
- 7. Quan Y, Wang C, Wang L, Li G. Geriatric sarcopenia is associated with hypertension: a systematic review and metaanalysis. J Clin Hypertens (Greenwich). 2023;25(9):808-16. doi:10.1111/jch.14714.
- 8. Ai Y, Xu R, Liu L. The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021;13(1):93. doi:10.1186/s13098-021-00707-7.
- 9. Lin Y, Zhang Y, Shen X, Huang L, Yan S. Influence of glucose, insulin fluctuation, and glycosylated hemoglobin on the outcome of sarcopenia in patients with type 2 diabetes mellitus. J Diabetes Complications. 2021;35(6):107926. doi:10.1016/j.jdiacomp.2021.107926.
- 10. Yamaguchi R, Katayama O, Lee S, Makino K, Harada K, Morikawa M, et al. Association of sarcopenia and systolic blood pressure with mortality: a 5-year longitudinal study. Arch Gerontol Geriatr. 2023;110:104988. doi:10.1016/j. archger.2023.104988.